<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04430569</url>
  </required_header>
  <id_info>
    <org_study_id>P160924</org_study_id>
    <secondary_id>P160924</secondary_id>
    <secondary_id>PHRCN-16-0580</secondary_id>
    <secondary_id>2018-000816-96</secondary_id>
    <nct_id>NCT04430569</nct_id>
  </id_info>
  <brief_title>Pulmonary Embolism International THrOmbolysis Study-3</brief_title>
  <acronym>PEITHO-3</acronym>
  <official_title>A Reduced Dose of Thrombolytic Treatment for Patients With Intermediate High-risk Acute Pulmonary Embolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Medical Center of the Johannes Gutenberg University Mainz, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Life Sciences Research Partners (D Collen Research Foundation)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we will assess the efficacy and safety of a reduced dose of thrombolytic
      therapy given in addition to low-molecular-weight heparin in patients with
      intermediate-high-risk acute pulmonary embolism. Half of participants will receive
      thrombolytic treatment, while the other half will receive a placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In patients with intermediate-risk pulmonary embolism, full-dose thrombolytic treatment was
      associated with a reduction in the combined risk of hemodynamic instability or death but was
      also associated with an increased risk of major and intracranial bleeding. Previous studies
      suggest that reduced dose of thrombolytic treatment may be as effective as the full dosage,
      but with a decreased risk of life-threatening bleeding. In this study, we will assess the
      efficacy and safety of a reduced dosage of thrombolytic therapy in patients with
      intermediate-high-risk acute pulmonary embolism.

      The study is a randomized, placebo-controlled, double blind, multicenter, multinational trial
      with long-term follow-up.

      Patients fulfilling the inclusion criteria and without any of the exclusion criteria will be
      randomized within 6 hours after the investigator had confirmed the diagnosis.

      Patients will receive:

        -  Alteplase (if randomized in the experimental group) or placebo (if randomized in the
           reference group) given within 30 minutes of randomization as a 15 min intravenous
           infusion at a dosage of 0.6 mg/kg with a total dose not exceeding 50 mg.

        -  Low molecular weight heparin at therapeutic doses according to local practice

      Primary objective is to assess the efficacy of reduced dose thrombolytic therapy in patients
      with acute intermediate-high-risk pulmonary embolism at day 30.

      Secondary objectives are:

        1. To assess the safety of reduced dose thrombolytic therapy in patients with
           intermediate-high-risk acute pulmonary embolism at day 30

        2. To assess the net clinical benefit of reduced dose thrombolytic therapy in patients with
           intermediate-high-risk acute pulmonary embolism at day 30

        3. To assess the effect of reduced dose thrombolytic therapy on overall mortality of
           patients with intermediate-high-risk acute pulmonary embolism at day 30

        4. To assess the effect of reduced dose thrombolytic therapy on long-term mortality,
           functional impairment, residual right ventricular dysfunction and chronic thromboembolic
           pulmonary hypertension at 6 months and 2 years
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2020</start_date>
  <completion_date type="Anticipated">September 2027</completion_date>
  <primary_completion_date type="Anticipated">October 2025</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of (1) death from any cause or (2) hemodynamic decompensation or (3) objectively confirmed recurrent PE.</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fatal or GUSTO severe or life threatening bleeding</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite of the primary efficacy endpoint and GUSTO severe or life-threatening bleeding</measure>
    <time_frame>30 days</time_frame>
    <description>Assessment of net clinical benefit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PE related death</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic decompensation</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrent PE</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for rescue thrombolysis, catheter-directed treatment or surgical embolectomy</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ischemic or hemorrhagic stroke</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serious adverse events</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persisting dyspnea</measure>
    <time_frame>180 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persisting dyspnea</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent right ventricular dysfunction</measure>
    <time_frame>180 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent right ventricular dysfunction</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional outcome</measure>
    <time_frame>180 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional outcome</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Confirmed chronic thromboembolic pulmonary hypertension</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">650</enrollment>
  <condition>Pulmonary Embolism</condition>
  <arm_group>
    <arm_group_label>Alteplase</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alteplase</intervention_name>
    <description>Alteplase single intravenous infusion of 0.6 mg/kg of estimated bodyweight with a maximum of 50 mg given over 15 minutes.</description>
    <arm_group_label>Alteplase</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo single intravenous infusion of 0.6 mg/kg of estimated bodyweight with a maximum of 50 mg given over 15 minutes.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  Objectively confirmed acute PE with first symptoms occurring 2 weeks or less before
             randomization. Objective confirmation is based on at least one of the following
             criteria: (a) at least one segmental ventilation-perfusion mismatch on lung scanning;
             (b) a spiral computed tomography pulmonary angiography or pulmonary angiography
             showing a filling defect or an abrupt obstruction of a segmental or more proximal
             pulmonary artery

          -  Objective confirmation of acute PE within the past 24 hours

          -  Elevated risk of early death, or of hemodynamic collapse, or PE recurrence, indicated
             by at least one of the following criteria: (a) systolic blood pressure ≤ 110 mm Hg
             over at least 15 minutes upon enrolment, (b) temporary need for fluid resuscitation
             and/or treatment with low-dose catecholamines, provided that the patient could be
             stabilized within 2 hours of admission and maintains SBP of ≥ 90 mmHg and adequate
             organ perfusion without catecholamine infusion; (c) respiratory rate &gt; 20/min or
             oxygen saturation on pulse oximetry SpO2 &lt;90% o(or partial arterial oxygen pressure &lt;
             60 mm Hg) at rest while breathing room air, (d) history of chronic heart failure

          -  Right ventricular dysfunction indicated by RV/LV diameter ratio &gt;1.0 on
             echocardiography apical four-chamber or subcostal four-chamber view or on Computed
             Tomography Pulmonary Angiography (transverse plane)

          -  Serum troponin I or T concentration above the upper limit of local normal using a
             high-sensitive assay

          -  Patient should be randomized within 6 hours after the investigator receives the
             results of the imaging test(s) confirming right ventricular dysfunction (RV/LV
             diameter ratio &gt;1.0) and the laboratory tests showing a serum troponin I or T
             concentration above the upper limit of local normal, whichever comes latest.

          -  Signed informed consent

        Exclusion Criteria:

          -  Hemodynamic instability

          -  Active bleeding

          -  History of non-traumatic intracranial bleeding, any time

          -  Acute ischemic stroke within 6 months

          -  Known central nervous system neoplasm/metastasis

          -  Neurologic, ophthalmologic, abdominal, cardiac, thoracic, vascular or orthopedic
             surgery or trauma within 3 weeks

          -  Platelet count &lt; 100 G/L

          -  INR &gt; 1.4

          -  Treatment with antiplatelet agents other than (a) acetylsalicylic acid (ASA) ≤ 100 mg
             once daily or (b) clopidogrel 75 mg once daily or (c) a single loading dose of ASA or
             clopidogrel. Dual antiplatelet therapy (ASA + clopidogrel) is not allowed.

          -  Any direct oral anticoagulant within 12 hours of inclusion

          -  Uncontrolled hypertension &gt; 180/90 mm Hg at the time of inclusion

          -  Known pericarditis or endocarditis

          -  Known significant bleeding risk according to the physician's judgement

          -  Administration of thrombolytic agents within the previous 4 days

          -  Vena cava filter insertion or pulmonary thrombectomy within the previous 4 days

          -  Current participation in another interventional clinical study

          -  Previous enrolment in this study

          -  Known hypersensitivity to alteplase, gentamicin (a residue of the Actilyse®
             manufacturing process present in trace amounts), any of the excipients of Actilyse®,
             or low-molecular weight heparin

          -  Known previous immune heparin-induced thrombocytopenia

          -  Known severe liver disease (grade ≥ 3) including liver failure, cirrhosis, portal
             hypertension (esophageal varices) and active hepatitis

          -  Acute symptomatic pancreatitis

          -  Gastrointestinal ulcers or esophageal varices, documented within the past 3 months

          -  Known arterial aneurysm, arterial or venous malformations

          -  Pregnancy or parturition within the previous 30 days or current breastfeeding.

          -  Women of childbearing potential who do not have a negative pregnancy test and do not
             use one of the following methods of birth control: hormonal contraception or
             intrauterine device or bilateral tubal occlusion

          -  Any other condition that the investigator feels would place the patient at increased
             risk upon start of the investigational treatment

          -  Life expectancy of less than 6 months or inability to complete 6-month follow-up.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guy Meyer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stavros Konstantinides, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Mainz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guy Meyer</last_name>
    <email>guy.meyer@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yvann Frigout</last_name>
    <email>yvann.frigout@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Graz, Mediz Universität</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <contact>
      <last_name>Andrea Zirlik, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCL Brussels</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
    <contact>
      <last_name>Franck Verschuren, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>KU Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <contact>
      <last_name>Thomas Vanassche, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Liège</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <contact>
      <last_name>Alexandre Ghuysen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Jason Weatherald, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hamilton Health Sciences and St Jospeh's Hospital Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>James Douketis, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kingston Health Sciences Centre</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Kerstin de Wit, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre Res. Inc.</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Justin Yang, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hopsital, General and Civic campuses</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Lana Castellucci, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jewish General Hospital</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Andrew Hirsch, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU d'Angers</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Pierre-Marie Roy, MD</last_name>
      <email>pmroy@chu-angers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Besançon - Hôpital Jean-Minjoz</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Nicolas Meneveau, MD</last_name>
      <email>nicolas.meneveau@univ-fcomte.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Brest - Hôpital de la Cavale Blanche</name>
      <address>
        <city>Brest</city>
        <zip>29000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Couturaud, MD</last_name>
      <email>francis.couturaud@chu-brest.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Tours - Hôpital Trousseau</name>
      <address>
        <city>Chambray-lès-Tours</city>
        <zip>37170</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Denis Angoulvant, MD</last_name>
      <email>d.angoulvant@chu-tours.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand - Hôpital Gabriel Montpied</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Jeannot Schmidt, MD</last_name>
      <email>jschmidt@chu-clermontferrand.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AP-HP - hôpital Henri-Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Pascal Lim, MD</last_name>
      <email>pascal.lim@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble - Hôpital Michallon</name>
      <address>
        <city>La Tronche</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Hélène Bouvaist, MD</last_name>
      <email>hbouvaist@chu-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Lille - Institut Cœur Poumon</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Nicolas Lemblin, MD</last_name>
      <email>nicolas.lamblin@chru-lille.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HCL - Hôpital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Karim Tazarourte, MD</last_name>
      <email>karim.tazarourte@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HCL - Hôpital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Laurent Argaud, MD</last_name>
      <email>laurent.argaud@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AP-HM - Hôpital de la Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Gabrielle Sarlon-Bartoli, MD</last_name>
      <email>gabrielle.sarlon@ap-hm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Montpellier - Hôpital Lapeyronie</name>
      <address>
        <city>Montpellier</city>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Mustapha Sebbane, MD</last_name>
      <email>m-sebbane@chu-montpellier.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Nice - Hôpital Pasteur</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Emile Ferrari, MD</last_name>
      <email>ferrari.e@chu-nice.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AP-HP - Hôpital Lariboisière</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Jean-Guillaume Dillinger, MD</last_name>
      <email>jean-guillaume.dillinger@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AP-HP - hôpital européen Georges-Pompidou</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Benjamin Planquette, MD</last_name>
      <email>benjamin.planquette@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AP-HP - Hôpital Bichat-Claude-Bernard</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Grégory Ducrocq, MD</last_name>
      <email>gregory.ducrocq@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AP-HP - Hôpital Tenon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Aude Gibelin, MD</last_name>
      <email>aude.gibelin@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HCL - Centre Hospitalier Lyon-Sud</name>
      <address>
        <city>Pierre-Bénite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Marion Douplat, MD</last_name>
      <email>marion.douplat@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Saint-Étienne - Hôpital Nord</name>
      <address>
        <city>Saint-Étienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Laurent Bertoletti, MD</last_name>
      <email>laurent.bertoletti@chu-st-etienne.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Strasbourg - Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Patrick Ohlmann, MD</last_name>
      <email>patrick.ohlmann@chu-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse - Hôpital Rangueil</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Caroline Biendel-Piquet, MD</last_name>
      <email>biendel.c@chu-toulouse.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Berlin, Universitättsmedizin-Charité</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Burkert Pieske, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Berlin, DRK Kliniken Westend</name>
      <address>
        <city>Berlin</city>
        <zip>14050</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Christian Opitz, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dresden, Städtisches Klinikum</name>
      <address>
        <city>Dresden</city>
        <zip>01067</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Sebastian Schellong, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Düsseldorf, Augusta-Krankenhaus</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40472</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Anamaria Wolf-Pütz, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Freiburg Universität</name>
      <address>
        <city>Freiburg</city>
        <zip>79085</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Daniel Dürschmied, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Greifswald, Univ.-Medizin</name>
      <address>
        <city>Greifswald</city>
        <zip>17489</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Ralf Eswert, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Göttingen, Univ.-Medizin</name>
      <address>
        <city>Göttingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Gerd Hasenfuß, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hamburg, Universitäres Herzzentrum</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Stefan Blankenberg, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hannover, Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Andreas Schäfer, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Augustinerinnen Hospital</name>
      <address>
        <city>Köln</city>
        <zip>50678</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Ingo Ahrens, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cologne Universität Herzzentrum</name>
      <address>
        <city>Köln</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Stephan Rosenkranz, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leipzig, Univ.-Klinikum</name>
      <address>
        <city>Leipzig</city>
        <zip>4103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Sirak Petros, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mainz Universitätsmedizin, CTH</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Stavros Konstantinides, MD</last_name>
      <email>stavros.konstantinides@unimedizin-mainz.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mainz, Katholisches Klinikum</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Sabine Genth-Zotz, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regensburg, Uniklinik</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Tobias Lange, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tübingen, Univ.-Klinikum</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Tobias Geisler, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ulm, Universitätsklinikum</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Armin Imhof, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Ancona / Ospedali Riunit</name>
      <address>
        <city>Ancona</city>
        <zip>60020</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Aldo Salvi, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Poliambulanza Hospital - Brescia</name>
      <address>
        <city>Brescia</city>
        <zip>25124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Claudio Cuccia, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spedali Riuniti - Cremona</name>
      <address>
        <city>Cremona</city>
        <zip>26100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Enrico Passamonti, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale San Giuseppe - Empoli</name>
      <address>
        <city>Empoli</city>
        <zip>50053</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Simone Vanni, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Careggi - Firenze</name>
      <address>
        <city>Firenze</city>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Maddalena Ottaviani, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Poma - Mantova</name>
      <address>
        <city>Mantova</city>
        <zip>46100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Antonio Izzo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Humanitas Hospital - Milano</name>
      <address>
        <city>Milano</city>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Corrado Lodigiani, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Perugia</name>
      <address>
        <city>Perugia</city>
        <zip>06123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Cecilia Becattini, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Ca Foncello - Treviso</name>
      <address>
        <city>Treviso</city>
        <zip>31100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Michele Diamanti, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Haaglanden hospital</name>
      <address>
        <city>Den Haag</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catharina hospital</name>
      <address>
        <city>Eindhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medisch Spectrum Twente</name>
      <address>
        <city>Enschede</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Martini hospital</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maasstad hospital</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Antonius hospital</name>
      <address>
        <city>Sneek</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Isala hospital</name>
      <address>
        <city>Zwolle</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of Bialystok</name>
      <address>
        <city>Białystok</city>
        <country>Poland</country>
      </address>
    </facility>
    <contact>
      <last_name>Bożena Sobkowicz, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Cardiac and Vascular Diseases</name>
      <address>
        <city>Kraków</city>
        <country>Poland</country>
      </address>
    </facility>
    <contact>
      <last_name>Piotr Podolec, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Poznan University of Medical Sciences</name>
      <address>
        <city>Poznań</city>
        <country>Poland</country>
      </address>
    </facility>
    <contact>
      <last_name>Tatiana Mularek, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
    <contact>
      <last_name>Zbigniew Gaciong, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of Lodz</name>
      <address>
        <city>Łódź</city>
        <country>Poland</country>
      </address>
    </facility>
    <contact>
      <last_name>Jarosław Kasprzak, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Garcia de Orta</name>
      <address>
        <city>Almada</city>
        <country>Portugal</country>
      </address>
    </facility>
    <contact>
      <last_name>Melanie Ferreira, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar de Lisboa Norte/ Hospitalde Santa Maria</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
    <contact>
      <last_name>Rui Placido, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar de Lisboa Ocidental</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
    <contact>
      <last_name>Hugo Moreira, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Pedro Hispano</name>
      <address>
        <city>Matosinhos</city>
        <country>Portugal</country>
      </address>
    </facility>
    <contact>
      <last_name>Carolina Guedes, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar do Porto</name>
      <address>
        <city>Porto</city>
        <country>Portugal</country>
      </address>
    </facility>
    <contact>
      <last_name>Fabienne Gonçalves, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar de Setubal</name>
      <address>
        <city>Setúbal</city>
        <country>Portugal</country>
      </address>
    </facility>
    <contact>
      <last_name>Sonia Serra, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spitalul Judetean de Urgenta Baia Mare</name>
      <address>
        <city>Baia Mare</city>
        <zip>430031</zip>
        <country>Romania</country>
      </address>
    </facility>
    <contact>
      <last_name>Calin Pop, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bucuresti - Spitalul Clinic de Urgenta Sf. Pantelimon</name>
      <address>
        <city>Bucuresti</city>
        <country>Romania</country>
      </address>
    </facility>
    <contact>
      <last_name>Alexandru Nechita, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spitalul Judetean de Urgenta Constanta</name>
      <address>
        <city>Constanţa</city>
        <zip>900591</zip>
        <country>Romania</country>
      </address>
    </facility>
    <contact>
      <last_name>Anca Mihaela Radulescu, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Iasi - St Spiridon Emergency Conty Hospital</name>
      <address>
        <city>Iaşi</city>
        <zip>700111</zip>
        <country>Romania</country>
      </address>
    </facility>
    <contact>
      <last_name>Antoniu Petris, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institutul de Boli Cardio-Vasculare Timisoara</name>
      <address>
        <city>Timişoara</city>
        <country>Romania</country>
      </address>
    </facility>
    <contact>
      <last_name>Lucian Petrescu, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cardiology Clinic, Emergency Center, Clinical Center of Serbia</name>
      <address>
        <city>Belgrad</city>
        <country>Serbia</country>
      </address>
    </facility>
    <contact>
      <last_name>Branislav Stefanovic, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cardiology Clinic, Clinical Center of Niš</name>
      <address>
        <city>Niš</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute for Lung Diseases of Vojvodina, Sremska Kamenica</name>
      <address>
        <city>Novi Sad</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Centre Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
    <contact>
      <last_name>Matija Kozak, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Manuel Monreal, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Jorge Moises, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Bellvitge</name>
      <address>
        <city>Barcelona</city>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Antoni Riera-Mestre, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Cartagena</name>
      <address>
        <city>Cartagena</city>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Javier Trujillo-Santos, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Galdakao</name>
      <address>
        <city>Galdakao</city>
        <zip>48960</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Aitor Ballaz, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clínica Universitaria Navarra</name>
      <address>
        <city>Madrid</city>
        <zip>28027</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Pedro Ruiz-Artacho, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>David Jimenez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Remedios Otero, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Raquel Lopez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Araba</name>
      <address>
        <city>Vitoria</city>
        <zip>01009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Jose Luis Lobo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital fribourgeois</name>
      <address>
        <city>Fribourg</city>
        <zip>1752</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <contact>
      <last_name>Daniel Hayoz, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Geneva University Hospital</name>
      <address>
        <city>Geneva</city>
        <zip>1205</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <contact>
      <last_name>Marc Righini, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lausanne University Hospital</name>
      <address>
        <city>Lausanne</city>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <contact>
      <last_name>Lucia Mazzolai, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Romania</country>
    <country>Serbia</country>
    <country>Slovenia</country>
    <country>Spain</country>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Galiè N, Geibel A, Goldhaber SZ, Jimenez D, Kozak M, Kupatt C, Kucher N, Lang IM, Lankeit M, Meneveau N, Pacouret G, Palazzini M, Petris A, Pruszczyk P, Rugolotto M, Salvi A, Schellong S, Sebbane M, Sobkowicz B, Stefanovic BS, Thiele H, Torbicki A, Verschuren F, Konstantinides SV; PEITHO Investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014 Apr 10;370(15):1402-11. doi: 10.1056/NEJMoa1302097.</citation>
    <PMID>24716681</PMID>
  </reference>
  <reference>
    <citation>Barco S, Vicaut E, Klok FA, Lankeit M, Meyer G, Konstantinides SV; PEITHO Investigators. Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials. Eur Respir J. 2018 Jan 18;51(1). pii: 1701775. doi: 10.1183/13993003.01775-2017. Print 2018 Jan.</citation>
    <PMID>29348184</PMID>
  </reference>
  <reference>
    <citation>Konstantinides SV, Vicaut E, Danays T, Becattini C, Bertoletti L, Beyer-Westendorf J, Bouvaist H, Couturaud F, Dellas C, Duerschmied D, Empen K, Ferrari E, Galiè N, Jiménez D, Kostrubiec M, Kozak M, Kupatt C, Lang IM, Lankeit M, Meneveau N, Palazzini M, Pruszczyk P, Rugolotto M, Salvi A, Sanchez O, Schellong S, Sobkowicz B, Meyer G. Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism. J Am Coll Cardiol. 2017 Mar 28;69(12):1536-1544. doi: 10.1016/j.jacc.2016.12.039.</citation>
    <PMID>28335835</PMID>
  </reference>
  <reference>
    <citation>Marti C, John G, Konstantinides S, Combescure C, Sanchez O, Lankeit M, Meyer G, Perrier A. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2015 Mar 7;36(10):605-14. doi: 10.1093/eurheartj/ehu218. Epub 2014 Jun 10. Review.</citation>
    <PMID>24917641</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 10, 2020</study_first_submitted>
  <study_first_submitted_qc>June 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2020</study_first_posted>
  <last_update_submitted>June 10, 2020</last_update_submitted>
  <last_update_submitted_qc>June 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intermediate-high-risk acute pulmonary embolism</keyword>
  <keyword>Thrombolysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tissue Plasminogen Activator</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data (IPD) that underlie results in publication could be shared. IPD detailed in the protocol of a planned metaanalysis could be shared.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>One year after the last publication</ipd_time_frame>
    <ipd_access_criteria>Data sharing must be accepted by the sponsor and the PI based on scientific project and scientific involvement of the PI team. The founder could be involved in the decision.
Teams wishing obtain IPD must meet the sponsor and IP team to present scientifics (and commercial) purpose, IPD needed, format of data transmission, and timeframe. Technical feasibility and financial support will be discussed before mandatory contractualization.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

